Learn More
Medchemexpress LLC GNE-9815 | 2729996-45-4 | 98.9% | C26H22FN5O2 | 1 ML

Supplier: Medchemexpress LLC HY14216010MM/1ML
GNE-9815 is a highly selective, pan-RAF inhibitor exhibiting good oral bioavailability. It demonstrates potent inhibition of CRAF (Ki 0.062 nM) and BRAF (Ki 0.19 nM). When combined with the MEK inhibitor Cobimetinib, GNE-9815 shows synergistic modulation of the MAPK pathway, making it suitable for studies in KRAS mutant cancers.
- Highly selective pan-RAF inhibitor
- Good oral bioavailability
- Potent inhibition of CRAF and BRAF
- Synergistic with Cobimetinib in MAPK pathway modulation
- Useful in KRAS mutant cancer research
- Demonstrates synergistic antiproliferative activity against human A549 and HCT116 cancer cells
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.